Sanofi
SNY
745 hedge funds and large institutions have $10.1B invested in Sanofi in 2026 Q1 according to their latest regulatory filings, with 103 funds opening new positions, 302 increasing their positions, 213 reducing their positions, and 104 closing their positions.
42% more repeat investments, than reductions
Existing positions increased: 302 | Existing positions reduced: 213
0.42% less ownership
Funds ownership: 9.08% → 8.66% (-0.42%)
1% less first-time investments, than exits
New positions opened: 103 | Existing positions closed: 104
2% less funds holding
Funds holding: 757 → 745 (-12)
7% less capital invested
Capital invested by funds: $10.8B → $10.1B (-$706M)
14% less funds holding in top 10
Funds holding in top 10: 7 → 6 (-1)
16% less call options, than puts
Call options by funds: $96.6M | Put options by funds: $115M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Morgan Stanley
New York
|
+$159M |
| 2 |
Millennium Management
New York
|
+$154M |
| 3 |
JP Morgan Chase
New York
|
+$121M |
| 4 |
Alyeska Investment Group
Chicago,
Illinois
|
+$108M |
| 5 |
Franklin Resources
San Mateo,
California
|
+$96.3M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Dodge & Cox
San Francisco,
California
|
-$1.26B |
| 2 |
Wellington Management Group
Boston,
Massachusetts
|
-$142M |
| 3 |
Natixis Advisors
Boston,
Massachusetts
|
-$110M |
| 4 |
BlackRock
New York
|
-$101M |
| 5 |
Thrivent Financial for Lutherans
Minneapolis,
Minnesota
|
-$98.4M |
SNY Hedge Fund Activity: Q1 2026 in Review
745 of the 8,186 institutional investors tracked by Wall St. Rank reported a position in Sanofi (SNY) for Q1 2026, worth a combined $10.1B — down 6.5% from $10.8B a quarter earlier.
Sellers outnumbered buyers: 104 funds closed out of SNY and 103 opened new positions — a net loss of 1 holder — while 213 trimmed existing stakes and 302 added.
The largest buyer was Morgan Stanley, adding an estimated $159M. The largest seller was Dodge & Cox, cutting an estimated $1.26B.
- 745 institutional investors held Sanofi (SNY) as of Q1 2026, down from 757 in Q4 2025.
- Funds reported $10.1B of Sanofi stock for Q1 2026, down 6.5% quarter-over-quarter.
- 103 funds opened new Sanofi positions in Q1 2026 and 104 closed out, a net change of -1 holder.
- The largest Sanofi buyer in Q1 2026 was Morgan Stanley, an estimated $159M added.
- The largest Sanofi seller in Q1 2026 was Dodge & Cox, an estimated $1.26B sold.
Based on aggregated 13F filings for Q1 2026.